North America Arterial Blood Gas Kits Market

The North America arterial blood gas kits market is expected to grow from US$ 269.51 million in 2022 to US$ 476.57 million by 2030. It is estimated to grow at a CAGR of 7.4% from 2022 to 2030. 

Growing Prevalence of Metabolic and Kidney Diseases Fuels North America Arterial Blood Gas Kits Market

Arterial blood gas tests are used to detect an acid–base imbalance that can cause kidney failure; heart failure; and metabolic diseases, such as diabetes. Thus, the test is prescribed to people suffering from metabolic and kidney diseases. Furthermore, as per the National Kidney Foundation, an estimated 37 million people (i.e., 15% of the adult population) in the US suffer from chronic kidney disease (CKD). It also mentioned that, in 2018, ∼ 785,883 Americans were suffering from kidney failure and needed dialysis or a kidney transplant to survive. Thus, the high prevalence of metabolic and kidney diseases drives the growth of the arterial blood gas kits market.

North America Arterial Blood Gas Kits Market Overview

The North America arterial blood gas kits market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North American arterial blood gas kits market in 2022. The growth of the arterial blood gas kits market is primarily driven by public awareness regarding blood sampling kits and the increasing number of research and collaboration to explore innovative therapeutic applications. The market in the North America region is also likely to spur with the presence of various key players in the market. In addition, the adoption of medical devices in healthcare operations for improving quality and reducing costs is also responsible for augmenting the growth of the arterial blood gas kits market in North American countries.

North America Arterial Blood Gas Kits Market Revenue and Forecast to 2030 (US$ Million)

North America Arterial Blood Gas Kits Strategic Insights

Strategic insights for the North America Arterial Blood Gas Kits provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Arterial Blood Gas Kits Report Scope

North America Arterial Blood Gas Kits Regional Insights

The geographic scope of the North America Arterial Blood Gas Kits refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Arterial Blood Gas Kits Market Segmentation 

The North America arterial blood gas kits market is segmented into product, type, application, usage, needle gauge, syringe volume, end user, and country.

Based on product, the North America arterial blood gas kits market is segmented into luer lock syringe and luer slip syringe. The luer lock syringe segment held a larger North America arterial blood gas kits market share in 2022.

Based on type, the North America arterial blood gas kits market is segmented into vented and non-vented. The non-vented segment held segment held a larger North America arterial blood gas kits market share in 2022.

Based on usage, the North America arterial blood gas kits market is segmented into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held a larger North America arterial blood gas kits market share in 2022.

Based on application, the North America arterial blood gas kits market is segmented into In vitro diagnostics, electrolyte analysis, and pH blood gas. The In vitro diagnostics segment held the largest North America arterial blood gas kits market share in 2022.

Based on needle guage, the North America arterial blood gas kits market is segmented into 23 G to 25 G and less than 23 G. The 23 G to 25 G segment held a larger North America arterial blood gas kits market share in 2022.

Based on syringe volume, the North America arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3 ml segment held the largest North America arterial blood gas kits market share in 2022. 

Based on end user, the North America arterial blood gas kits market is segmented into hospitals, clinics, and others. The hospitals segment held the largest North America arterial blood gas kits market share in 2022.

Based on country, the North America arterial blood gas kits market has been categorized into the US, Canada, and Mexico. The US dominated the North America arterial blood gas kits market in 2022.  

Becton Dickinson and Co, Vyaire Medical Inc, Opti Medical Systems, ICU Medical Inc, SunMed LLC, Trudell Healthcare Solutions Inc, Siemens Healthineers AG, Radiometer Medical ApS, ITL health Group Ltd, Medline Industries LP, Cardinal Health Inc, Fisher Scientific International, Inc., and Teleflex Inc are some of the leading companies operating in the North America arterial blood gas kits market.